Platelet factor XIII-A regulates platelet function and promotes clot retraction and stability
Carregando...
Citações na Scopus
3
Tipo de produção
article
Data de publicação
2023
Título da Revista
ISSN da Revista
Título do Volume
Editora
ELSEVIER
Autores
MITCHELL, Joanne L.
LITTLE, Gemma
BYE, Alexander P.
UNSWORTH, Amanda J.
KRIEK, Neline
SAGE, Tanya
STAINER, Alexander
SANGOWAWA, Ibidayo
MORROW, Gael B.
Citação
RESEARCH AND PRACTICE IN THROMBOSIS AND HAEMOSTASIS, v.7, n.5, article ID e100200, 15p, 2023
Resumo
Background: Factor XIII (FXIII) is an important proenzyme in the hemostatic system. The plasma-derived enzyme activated FXIII cross-links fibrin fibers within thrombi to increase their mechanical strength and cross-links fibrin to fibrinolytic inhibitors, specifically & alpha;2-antiplasmin, to increase resistance to fibrinolysis. We have previously shown that cellular FXIII (factor XIII-A [FXIII-A]), which is abundant in the platelet cytoplasm, is externalized onto the activated membrane and cross-links extracellular substrates. The contribution of cellular FXIII-A to platelet activation and platelet function has not been extensively studied.Objectives: This study aims to identify the role of platelet FXIII-A in platelet function. Methods: We used normal healthy platelets with a cell permeable FXIII inhibitor and platelets from FXIII-deficient patients as a FXIII-free platelet model in a range of platelet function and clotting tests.Results: Our data demonstrate that platelet FXIII-A enhances fibrinogen binding to the platelet surface upon agonist stimulation and improves the binding of platelets to fibrinogen and aggregation under flow in a whole-blood thrombus formation assay. In the absence of FXIII-A, platelets show reduced sensitivity to agonist stimulation, including decreased P-selectin exposure and fibrinogen binding. We show that FXIII-A is involved in platelet spreading where a lack of FXIII-A reduces the ability of platelets to fully spread on fibrinogen and collagen. Our data demonstrate that platelet FXIII-A is important for clot retraction where clots formed in its absence retracted to a lesser extent.Conclusion: Overall, this study shows that platelet FXIII-A functions during thrombus formation by aiding platelet activation and thrombus retraction in addition to its antifibrinolytic roles.
Palavras-chave
clot retraction, factor XIII, fibrinogen, fibrinolysis, platelet activation, platelet
Referências
- Agbani EO, 2017, BLOOD, V130, P2171, DOI 10.1182/blood-2017-05-787259
- Aleman MM, 2014, J CLIN INVEST, V124, P3590, DOI 10.1172/JCI75386
- Anokhin BA, 2020, FEBS J, V287, P452, DOI 10.1111/febs.15040
- BULUK K, 1955, Pol Tyg Lek (Wars), V10, P191
- Calaminus SDJ, 2008, J THROMB HAEMOST, V6, P1944, DOI 10.1111/j.1538-7836.2008.03141.x
- COHEN I, 1980, BIOCHIM BIOPHYS ACTA, V628, P365, DOI 10.1016/0304-4165(80)90386-4
- COHEN I, 1979, ARCH BIOCHEM BIOPHYS, V192, P100, DOI 10.1016/0003-9861(79)90075-4
- Dale GL, 2002, NATURE, V415, P175, DOI 10.1038/415175a
- Dunster JL, 2021, BLOOD ADV, V5, P4017, DOI 10.1182/bloodadvances.2020003261
- Flaumenhaft R, 2005, BLOOD, V105, P3879, DOI 10.1182/blood-2004-04-1392
- Flevaris P, 2007, J CELL BIOL, V179, P553, DOI 10.1083/jcb.200703185
- Fraser SR, 2011, BLOOD, V117, P6371, DOI 10.1182/blood-2011-02-333203
- Gibbins JM, 2004, J CELL SCI, V117, P3415, DOI 10.1242/jcs.01325
- Ginsberg Mark H., 1992, Current Opinion in Cell Biology, V4, P766, DOI 10.1016/0955-0674(92)90099-X
- GLADNER JA, 1983, THROMB RES, V30, P273, DOI 10.1016/0049-3848(83)90081-6
- HARTWIG JH, 1992, J CELL BIOL, V118, P1421, DOI 10.1083/jcb.118.6.1421
- Kasahara K, 2013, BLOOD, V122, P3340, DOI 10.1182/blood-2013-04-491290
- Kasahara K, 2010, BLOOD, V115, P1277, DOI 10.1182/blood-2009-06-227645
- Kattula S, 2018, BLOOD ADV, V2, P25, DOI 10.1182/bloodadvances.2017011890
- KIESSELBACH TH, 1966, AM J PHYSIOL, V211, P1472, DOI 10.1152/ajplegacy.1966.211.6.1472
- Klages B, 1999, J CELL BIOL, V144, P745, DOI 10.1083/jcb.144.4.745
- Kotova YN, 2019, THROMB HAEMOSTASIS, V119, P906, DOI 10.1055/s-0039-1683912
- KOVACSOVICS TJ, 1995, J BIOL CHEM, V270, P11358, DOI 10.1074/jbc.270.19.11358
- Kulkarni S, 2004, J BIOL CHEM, V279, P30697, DOI 10.1074/jbc.M403559200
- LOPACIUK S, 1976, THROMB RES, V8, P453, DOI 10.1016/0049-3848(76)90223-1
- LUSCHER E F, 1957, Schweiz Med Wochenschr, V87, P1220
- Magwenzi SG, 2011, J THROMB HAEMOST, V9, P820, DOI 10.1111/j.1538-7836.2011.04234.x
- Mattheij NJA, 2016, HAEMATOLOGICA, V101, P427, DOI 10.3324/haematol.2015.131441
- Mitchell JL, 2023, J THROMB HAEMOST, V21, P2248, DOI 10.1016/j.jtha.2023.03.044
- Mitchell JL, 2014, BLOOD, V124, P3982, DOI 10.1182/blood-2014-06-583070
- MOCKROS LF, 1974, BIOPHYS CHEM, V2, P164, DOI 10.1016/0301-4622(74)80037-2
- MUSZBEK L, 1993, THROMB HAEMOSTASIS, V69, P282
- Mutch NJ, 2010, J THROMB HAEMOST, V8, P2017, DOI 10.1111/j.1538-7836.2010.03963.x
- Muthard RW, 2012, ARTERIOSCL THROM VAS, V32, P2938, DOI 10.1161/ATVBAHA.112.300312
- Nagy B, 2009, THROMB HAEMOSTASIS, V102, P83, DOI 10.1160/TH09-01-0054
- PISANO JJ, 1968, SCIENCE, V160, P892, DOI 10.1126/science.160.3830.892
- Pleines I, 2012, BLOOD, V119, P1054, DOI 10.1182/blood-2011-08-372193
- Poulter NS, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8254
- REED GL, 1991, T ASSOC AM PHYSICIAN, V104, P21
- SAKATA Y, 1980, J CLIN INVEST, V65, P290, DOI 10.1172/JCI109671
- SCHWARTZ ML, 1971, J BIOL CHEM, V246, P5851
- Serrano K, 2002, THROMB HAEMOSTASIS, V88, P315
- SHEN L, 1983, J CLIN INVEST, V71, P1336, DOI 10.1172/JCI110885
- SIXMA JJ, 1984, THROMB HAEMOSTASIS, V51, P388
- Sun HF, 2018, J CELL PHYSIOL, V233, P7497, DOI 10.1002/jcp.26603
- Vaiyapuri S, 2012, CIRCULATION, V125, P2479, DOI 10.1161/CIRCULATIONAHA.112.101246
- Whyte CS, 2017, SEMIN THROMB HEMOST, V43, P115, DOI 10.1055/s-0036-1597283
- Whyte CS, 2015, BLOOD, V125, P2568, DOI 10.1182/blood-2014-09-599480